Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast

Breast Cancer Research and Treatment

Volumn 65, Issue 1, 2001, Pages 23-29

  Berner, H S ^a   Nesland, J M ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

CD44; Immunohistochemistry; Infiltrating lobular carcinoma

Indexed keywords

ESTROGEN RECEPTOR; HERMES ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIGENS, CD44; BREAST NEOPLASMS; CARCINOMA, LOBULAR; CELL MEMBRANE; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035117134     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006417412046     Document Type: Article

References (34)

1. CD44H regulates tumor cell migration on hyaluronate-coated substrate
2. The human and mouse receptors for hyaluronan-mediated motility, RHAMM, genes (HMMR) map to human chromosome 5q33.2-qter and mouse chromosome 11
3. CD44 isoforms during differentiation and development
4. The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms
5. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
6. De-novo expression of CD44 and survival in gastric cancer
7. Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript
8. Colorectal cancer prognosis and expression of exon-v6-containing CD 44 proteins
9. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients
10. Prognostic value of CD44 splice variants in human stage III cervical cancer
11. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation
12. CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor
13. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer
14. CD44-a new prognostic marker for neuroblastoma
15. CD44 isoforms in prognosis of breast cancer
16. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas
17. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer
18. Coexpression of CD44 variant (vl0/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis
19. CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma
20. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression
21. Glycoprotein CD44 expression and its association with survival in breast cancer
22. Significance of CD44 gene products for cancer diagnosis and disease evaluation
23. CD44 variant expression and estrogen receptor status in breast cancer
24. Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
25. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer
26. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia
27. CD44 is a marker of endocervical neoplasia
28. Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products
29. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours
30. CD44 expression in sinonasal melanomas: Is loss of isoform expression associated with advanced tumour stage?
31. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse
32. Invasive lobular carcinoma of the breast. The importance of an alveolar growth pattern
33. CD44 variant exon epitopes in primary breast cancer and length of survival
34. CD44v6 is not a prognostic factor in primary breast cancer